Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Size

• The Asia-Pacific dual emission X-Ray absorptiometry (DEXA) equipment market size was valued at USD 1.55 billion in 2025 and is expected to reach USD 2.68 billion by 2033, at a CAGR of 7.12% during the forecast period
• The market growth is largely fueled by the increasing prevalence of bone-related disorders such as osteoporosis and osteopenia, along with the growing geriatric population worldwide, which is significantly increasing the demand for advanced bone density diagnostic solutions. The rising awareness regarding early diagnosis and prevention of bone health conditions is further encouraging the adoption of Dual Emission X-Ray Absorptiometry (DEXA) equipment across hospitals and diagnostic centers
• Furthermore, rising demand for accurate, non-invasive, and reliable bone mineral density (BMD) testing, along with continuous technological advancements in medical imaging systems, is establishing DEXA equipment as a standard diagnostic tool for bone health assessment and body composition analysis. These converging factors are accelerating the uptake of Dual Emission X-Ray Absorptiometry (DEXA) equipment solutions, thereby significantly boosting the industry's growth

Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Analysis

• Dual Emission X-Ray Absorptiometry (DEXA) equipment, widely used for measuring bone mineral density and diagnosing conditions such as osteoporosis and osteopenia, has become an essential diagnostic technology in modern healthcare systems due to its high accuracy, low radiation exposure, and ability to provide detailed bone health and body composition analysis
• The escalating demand for DEXA equipment is primarily driven by the rising prevalence of osteoporosis and other bone-related disorders, the rapidly growing geriatric population, and increasing awareness regarding early diagnosis and preventive healthcare. In addition, technological advancements in imaging systems and expanding use of DEXA scans in sports medicine and obesity management are further supporting market growth
• China dominated the dual emission X-Ray absorptiometry (DEXA) equipment market with the largest revenue share of approximately 31.7% in 2025, supported by the country’s large patient population, increasing investments in healthcare infrastructure, and expanding adoption of advanced diagnostic imaging technologies across hospitals and diagnostic centers
• India is expected to be the fastest-growing market for dual emission x-ray absorptiometry (DEXA) equipment during the forecast period due to improving healthcare infrastructure, rising awareness regarding osteoporosis screening, growing geriatric population, and increasing government initiatives aimed at strengthening diagnostic capabilities across healthcare facilities
• The central DEXA segment dominated the largest market revenue share of approximately 64.3% in 2025, driven by its high accuracy and widespread use in hospitals and diagnostic centers for comprehensive bone density measurements

Report Scope and Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Segmentation    

Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Trends

Increasing Adoption of Bone Density Screening and Preventive Diagnostics

• A significant and accelerating trend in the Dual Emission X-Ray Absorptiometry (DEXA) Equipment market is the growing emphasis on preventive healthcare and early diagnosis of bone-related disorders such as osteoporosis and osteopenia. Healthcare providers are increasingly utilizing DEXA equipment for accurate bone mineral density measurement and fracture risk assessment
  • For instance, hospitals and diagnostic centers are expanding the use of DEXA scanning systems for routine screening programs aimed at identifying bone health issues at an early stage, particularly among aging populations and postmenopausal women who are at higher risk of osteoporosis
• Technological advancements in DEXA equipment, including improved imaging accuracy, faster scanning capabilities, and reduced radiation exposure, are further encouraging the adoption of these systems in clinical settings. These innovations enable healthcare professionals to perform efficient and reliable bone density assessments
• Furthermore, DEXA systems are increasingly being used for additional clinical applications such as body composition analysis, obesity management, and metabolic health monitoring, expanding their role beyond traditional bone density measurement
• The growing demand for preventive diagnostic services and increasing awareness regarding bone health are encouraging healthcare facilities to adopt advanced DEXA systems
• As a result, manufacturers are focusing on developing compact, high-performance DEXA equipment that improves diagnostic accuracy while supporting broader clinical applications in hospitals and diagnostic laboratories

Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Dynamics

Driver

Rising Prevalence of Osteoporosis and Growing Geriatric Population

• The increasing prevalence of osteoporosis and other bone-related disorders is a major factor driving the demand for Dual Emission X-Ray Absorptiometry (DEXA) equipment worldwide. Osteoporosis is becoming a significant public health concern, particularly among elderly populations and postmenopausal women who are more vulnerable to bone density loss
  • For instance, healthcare professionals widely rely on DEXA scanning systems to diagnose osteoporosis, monitor bone mineral density changes, and evaluate the effectiveness of treatment therapies aimed at improving bone health
• In addition, the rapidly growing global geriatric population is contributing significantly to the demand for bone density testing and preventive diagnostic procedures. As individuals age, the risk of fractures and bone-related complications increases, making early detection and monitoring essential
• Increasing healthcare expenditure, improving diagnostic infrastructure, and growing awareness regarding bone health are also encouraging the adoption of DEXA equipment in hospitals and specialized diagnostic centers
• Furthermore, government healthcare programs and screening initiatives aimed at reducing the burden of osteoporosis are supporting the wider use of bone density testing technologies
• These factors collectively are expected to significantly drive the growth of the global Dual Emission X-Ray Absorptiometry (DEXA) Equipment market during the forecast period

Restraint/Challenge

High Equipment Cost and Limited Accessibility in Developing Regions

• The high cost associated with advanced Dual Emission X-Ray Absorptiometry (DEXA) equipment represents a major challenge for the growth of the global market. The installation of DEXA systems requires substantial capital investment, which can limit adoption among smaller hospitals and diagnostic centers with limited budgets
• In addition, the need for specialized infrastructure and trained healthcare professionals to operate the equipment can further increase operational costs for healthcare facilities
• Limited access to advanced diagnostic technologies in developing regions can also restrict the widespread adoption of DEXA systems. Many healthcare facilities in rural or underserved areas may lack the necessary infrastructure to implement bone density testing services
• In addition, inadequate awareness regarding bone health and osteoporosis screening in certain regions may lead to lower utilization of DEXA diagnostic procedures
• Addressing these challenges through cost-effective equipment development, improved healthcare infrastructure, and greater awareness regarding bone health screening will be essential to support the long-term growth of the Dual Emission X-Ray Absorptiometry (DEXA) Equipment market

Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Scope

The Dual Emission X-Ray Absorptiometry (DEXA) Equipment market is segmented on the basis of product type, application, and end users.

• By Product Type

On the basis of product type, the Dual Emission X-Ray Absorptiometry (DEXA) Equipment market is segmented into central dual emission X-ray absorptiometry (DEXA) and peripheral dual emission X-ray absorptiometry (DEXA). The central DEXA segment dominated the largest market revenue share of approximately 64.3% in 2025, driven by its high accuracy and widespread use in hospitals and diagnostic centers for comprehensive bone density measurements. Central DEXA systems are primarily used to assess bone mineral density in critical areas such as the hip and spine, which are key indicators for diagnosing osteoporosis and evaluating fracture risk. Healthcare professionals prefer central DEXA scanners because they provide more precise and detailed diagnostic information compared to peripheral devices. The increasing prevalence of osteoporosis, particularly among the aging population, is significantly driving the demand for central DEXA equipment. In addition, these systems are widely used in research and clinical trials related to bone health and metabolic disorders. Continuous technological advancements have improved imaging resolution, scanning speed, and patient comfort, further supporting segment growth. Many healthcare institutions are investing in advanced central DEXA systems to improve diagnostic capabilities and support preventive healthcare strategies. The integration of advanced software for body composition analysis also enhances the functionality of central DEXA equipment. As awareness of bone health and early osteoporosis detection continues to grow globally, the central DEXA segment maintains a strong market position.

The peripheral DEXA segment is expected to witness the fastest CAGR of 7.9% from 2026 to 2033, driven by increasing adoption in outpatient settings and community health screening programs. Peripheral DEXA devices are designed to measure bone density in peripheral parts of the body such as the wrist, heel, or forearm, making them more compact and portable compared to central systems. These devices are widely used for preliminary osteoporosis screening due to their affordability and ease of use. The growing emphasis on preventive healthcare and early detection of bone diseases is significantly increasing the demand for portable diagnostic solutions. Peripheral DEXA equipment is also being adopted in pharmacies, clinics, and mobile health units to expand access to bone health assessments. In addition, healthcare providers in emerging economies are increasingly utilizing peripheral systems as cost-effective diagnostic tools. Technological improvements have enhanced the accuracy and reliability of peripheral scanners, making them more suitable for large-scale screening programs. Government initiatives promoting osteoporosis awareness and routine screening are further supporting the adoption of peripheral DEXA equipment. As healthcare systems focus on expanding diagnostic accessibility and early disease detection, this segment is expected to experience rapid growth.

• By Application

On the basis of application, the Dual Emission X-Ray Absorptiometry (DEXA) Equipment market is segmented into body composition analysis, fracture diagnosis, bone densitometry, and fracture risk assessment. The bone densitometry segment held the largest market revenue share of around 41.8% in 2025, driven by the growing need for accurate diagnosis and monitoring of osteoporosis and other bone-related disorders. Bone densitometry using DEXA technology is considered the gold standard for measuring bone mineral density and evaluating bone health. The increasing prevalence of osteoporosis, particularly among post-menopausal women and elderly individuals, has significantly boosted demand for DEXA-based bone density testing. Healthcare professionals rely on DEXA scans to identify patients at risk of fractures and to monitor the effectiveness of osteoporosis treatments. In addition, clinical guidelines from health organizations strongly recommend routine bone density screening for high-risk populations, which further supports segment growth. Hospitals and diagnostic centers are increasingly adopting advanced DEXA systems to enhance their diagnostic capabilities. The rising awareness of preventive healthcare and early disease detection also encourages individuals to undergo bone density screening. Technological advancements such as automated analysis software and improved imaging quality have further enhanced the reliability of bone densitometry tests. As global populations continue to age, the demand for bone density assessment procedures is expected to remain strong.

The body composition analysis segment is expected to register the fastest CAGR of 8.3% from 2026 to 2033, driven by the increasing use of DEXA technology in fitness, sports medicine, and metabolic health assessment. Body composition analysis allows healthcare professionals and fitness specialists to accurately measure fat mass, lean muscle mass, and bone mass in the human body. This capability makes DEXA scanners valuable tools not only in medical settings but also in research institutions and athletic performance centers. The growing prevalence of obesity and metabolic disorders is encouraging healthcare providers to adopt advanced body composition analysis tools for monitoring patient health. In addition, athletes and fitness professionals increasingly rely on DEXA technology to track muscle development and optimize training programs. Technological advancements have also improved the speed and precision of body composition measurements. Research studies focusing on nutrition, metabolism, and aging further contribute to the demand for DEXA-based body composition analysis. Healthcare institutions are increasingly integrating these tools into preventive health screening programs. As interest in personalized health monitoring continues to expand, the body composition analysis segment is expected to grow rapidly during the forecast period.

• By End Users

On the basis of end users, the Dual Emission X-Ray Absorptiometry (DEXA) Equipment market is segmented into hospitals, clinics, mobile health centres, and others. The hospitals segment dominated the market with the largest revenue share of approximately 46.5% in 2025, primarily due to the availability of advanced diagnostic infrastructure and specialized healthcare professionals. Hospitals frequently perform DEXA scans as part of routine diagnostic procedures for patients with suspected osteoporosis, bone disorders, and metabolic diseases. The presence of comprehensive imaging departments and multidisciplinary medical teams enables hospitals to provide accurate diagnosis and treatment planning. In addition, hospitals often handle complex cases that require advanced imaging technologies such as central DEXA systems. The increasing number of orthopedic and geriatric patients visiting hospitals for bone health assessments significantly contributes to the demand for DEXA equipment. Hospitals are also involved in clinical research and trials related to bone diseases, which further drives the adoption of advanced diagnostic technologies. Government investments in hospital infrastructure and healthcare modernization programs also support segment growth. Furthermore, hospitals provide integrated treatment and monitoring services for patients undergoing long-term osteoporosis management. As healthcare systems continue to strengthen hospital-based diagnostic services, this segment remains the leading end-user in the DEXA equipment market.

The mobile health centres segment is expected to witness the fastest CAGR of 8.1% from 2026 to 2033, driven by the increasing focus on expanding healthcare access in remote and underserved areas. Mobile health units equipped with portable diagnostic equipment are being widely deployed to conduct large-scale health screening programs, including bone density assessments. These centers allow healthcare providers to reach populations that may have limited access to hospitals or specialized diagnostic facilities. The growing emphasis on preventive healthcare and early detection of osteoporosis is encouraging governments and healthcare organizations to invest in mobile screening services. Portable DEXA devices are increasingly being integrated into mobile health units due to their compact design and efficient diagnostic capabilities. In addition, public health initiatives aimed at improving awareness about bone health are promoting the use of mobile diagnostic services. Healthcare providers are also leveraging mobile health centers to conduct community-based screening campaigns and educational programs. Technological advancements in lightweight and portable DEXA systems are further supporting this trend. As healthcare systems focus on improving accessibility and outreach, mobile health centres are expected to experience rapid growth in the coming years.

Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Regional Analysis

• The Asia-Pacific dual emission X-Ray absorptiometry (DEXA) equipment market is expected to witness significant growth during the forecast period, driven by improving healthcare infrastructure, increasing healthcare expenditure, and rising awareness regarding bone health and osteoporosis screening across several countries in the region
• The growing aging population and increasing prevalence of bone-related disorders are encouraging hospitals and diagnostic centers to adopt advanced bone density diagnostic technologies
• Furthermore, expanding healthcare facilities, increasing investments in medical imaging technologies, and the growing availability of diagnostic services are contributing to the rising adoption of DEXA equipment across countries such as China, India, and Japan. The increasing focus on preventive healthcare and early diagnosis of bone diseases is also supporting the growth of the market in the Asia-Pacific region

China Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Insight

The China dual emission X-Ray absorptiometry (DEXA) equipment market accounted for the largest revenue share of approximately 31.7% in the Asia-Pacific region in 2025, supported by the country’s large patient population, increasing investments in healthcare infrastructure, and expanding adoption of advanced diagnostic imaging technologies across hospitals and diagnostic centers. China is witnessing rapid development in healthcare facilities, along with growing awareness regarding osteoporosis diagnosis and bone health monitoring. The increasing demand for advanced medical imaging systems, combined with government initiatives aimed at improving healthcare services, is significantly contributing to the growth of the DEXA equipment market in the country.

India Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Insight

The India dual emission X-Ray absorptiometry (DEXA) equipment market is expected to be the fastest-growing market during the forecast period, driven by improving healthcare infrastructure and increasing awareness regarding osteoporosis screening and bone health management. The rising geriatric population, growing incidence of bone-related disorders, and expanding network of hospitals and diagnostic centers are encouraging the adoption of DEXA equipment across the country. In addition, increasing government initiatives aimed at strengthening diagnostic capabilities and improving access to advanced medical technologies are further supporting the growth of the DEXA equipment market in India.

Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market Share

The Dual Emission X-Ray Absorptiometry (DEXA) Equipment industry is primarily led by well-established companies, including:

• GE HealthCare (U.S.)
• Hologic, Inc. (U.S.)
• Fujifilm Holdings Corporation (Japan)
• Konica Minolta, Inc. (Japan)
• Swissray International, Inc. (U.S.)
• Diagnostic Medical Systems Group (France)
• Osteosys Co., Ltd. (South Korea)
• Medilink International Co., Ltd. (China)
• DMS Imaging (France)
• BeamMed Ltd. (Israel)
• Echolight S.p.A. (Italy)
• Xingaoyi Medical Equipment Co., Ltd. (China)
• Trivitron Healthcare (India)
• Mindray Medical International Limited (China)
• Hitachi Healthcare (Japan)
• Shimadzu Corporation (Japan)
• Canon Medical Systems Corporation (Japan)
• Siemens Healthineers (Germany)
• Philips Healthcare (Netherlands)

Latest Developments in Asia-Pacific Dual Emission X-Ray Absorptiometry (DEXA) Equipment Market

• In November 2024, Diagnostic Medical Systems (DMS) Imaging announced a strategic collaboration with OsteoSys to jointly develop and distribute next-generation dual-energy X-ray absorptiometry (DEXA) scanners across Europe and Asia. The partnership aims to expand access to advanced bone densitometry systems and accelerate innovation in osteoporosis screening and body composition analysis technologies
• In January 2025, OsteoSys unveiled the DXA-Lite, a compact and cost-effective DEXA bone densitometry system designed for community clinics and outpatient diagnostic centers. The device integrates automated vertebral fracture assessment and improved workflow capabilities, enabling broader adoption of bone density screening in smaller healthcare facilities
• In March 2025, Hologic, Inc., a global medical technology company specializing in women’s health and diagnostic imaging, announced a strategic partnership with Demetech to integrate artificial intelligence–enabled bone density analysis across its DEXA platforms. The collaboration aims to enhance fracture risk prediction, improve diagnostic accuracy, and streamline clinical workflows in osteoporosis management
• In April 2025, Hologic introduced a portable Horizon DXA system designed to support decentralized bone-health screening in outpatient clinics and mobile healthcare settings. The system enables healthcare providers to perform precise bone mineral density assessments while expanding access to osteoporosis diagnosis in remote and underserved regions
• In May 2025, Hologic announced the launch of a next-generation dual-energy X-ray absorptiometry (DEXA) system featuring enhanced image resolution and AI-assisted bone density analysis capabilities. The new system is designed to improve diagnostic accuracy, enable faster scans, and support clinicians in assessing fracture risk and monitoring osteoporosis treatment outcomes
• In January 2025, Siemens Healthineers announced a strategic collaboration with Mindray to integrate advanced DEXA data management and interoperability features into hospital information systems. The initiative aims to improve diagnostic workflows by enabling seamless sharing and analysis of bone density data across clinical platforms
• In February 2025, Swissray International announced the acquisition of Demetech AB to expand its footprint in the global DEXA equipment market. The acquisition strengthens Swissray’s capabilities in bone densitometry technology and supports the company’s strategy to broaden its portfolio of advanced diagnostic imaging solutions
• In April 2025, Newman Regional Health in the United States installed the Hologic Horizon DXA bone densitometry system to expand its diagnostic services for osteoporosis screening and body composition assessment. The addition of the advanced DEXA system enhances the hospital’s ability to provide early detection and monitoring of bone health conditions

SKU-16904